- The summit, a collaboration between the American Gastroenterological Association and the European Society of Neurogastroenterology and Motility, was held in Washington, D.C., focusing on the theme “crossing the threshold from lab to life.”
- Dr. Giovanni Barbara highlighted the extensive volume of gut microbiome research, with 24,000 articles published last year, emphasizing the field’s scientific importance.
- The opening keynote by Dr. Eran Elinav discussed a phage-based therapeutic pipeline for microbiome-associated diseases, with a focus on IBD.
- The sessions covered various topics, including:
- Improving health through the gut microbiome, with lectures on immunity, longevity, and microbiome changes in IBD.
- The growing market of microbiome-based products, addressing regulatory concerns and intellectual property strategies.